(Total Views: 508)
Posted On: 08/31/2025 6:16:59 PM
Post# of 158162
Multiple shots fired by Dr. J:
[00:06:03]:
Yeah. So I'm used to success and bring that attitude to what's happening now with CytoDyn because I very much believe in this drug. You said Pro-140, but we now call it Leronlimab.
[00:27:38]:
"....and we should point out that Leronlimab has been given to 1,600 patients or so and it's been very well tolerated and is not associated with any sort of dominant safety or toxicity issue which is not something you can really say about any other cancer drug."
Dr. J saying :
"We know what we own"
As Mr. Hoffman prepares to travel.
[00:06:03]:
Yeah. So I'm used to success and bring that attitude to what's happening now with CytoDyn because I very much believe in this drug. You said Pro-140, but we now call it Leronlimab.
[00:27:38]:
"....and we should point out that Leronlimab has been given to 1,600 patients or so and it's been very well tolerated and is not associated with any sort of dominant safety or toxicity issue which is not something you can really say about any other cancer drug."
Dr. J saying :
"We know what we own"
As Mr. Hoffman prepares to travel.
(5)
(0)
